We are pleased to invite investors and analysts to participate in our virtual event on Wednesday, 14 December 2022, highlighting Roche data presented at the American Society of Hematology 2022 Meeting and Exposition, from 10th to 13th December.   16:00 – 17:30 CET / 15:00 - 16:30 GMT 10:00 – 11:30 am EST / 7:00 – 8:30 am PST   An invitation with the detailed programme and registration link will follow soon.     Best regards,
Bruno Eschli Head of Investor Relations		Loren Kalm Head of Investor Relations, North America

Roche Investor Relations
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com	Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com
Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com

get the latest news and updates to your inbox.